U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07046806) titled 'Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients' on May 09.
Brief Summary: To assess the efficacy of prophylactic treatment with deucrictibant extended release (XR) tablet versus placebo in preventing angioedema attacks, and to also assess the efficacy of deucrictibant soft capsules as on-demand treatment versus placebo in achieving angioedema symptom relief during acute attacks.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Hereditary Angioedema (HAE)
Angioedema
Bradykinin-mediated Angioedema
C1 Inhibitor Deficiency
Intervention:
DRUG: Deucrictibant XR tablet
Deucri...